Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders: New Perspectives on Research and Treatment

389 Pages·2007·2.95 MB·English

by  Michael S. Ritsner (auth.)

Quality of Life Impairment in Schizophrenia,
Mood and Anxiety Disorders
Quality of Life Impairment
in Schizophrenia, Mood
and Anxiety Disorders
New Perspectives on Research and Treatment
Edited by
Michael S. Ritsner
Associate Professor, Department of Psychiatry, Faculty of Medicine,
Technion - Israel Institute of Technology, Haifa
Director, Acute Department, Sha’ar Menashe
Mental Health Center, Israel
Associate Editor, Quality of Life Research,
Amsterdam, The Netherlands
and
A. George Awad
Professor Emeritus, Department of Psychiatry and the Institute of Medical
Science University of Toronto Chief of Psychiatry, Humber River Regional
Hospital, Toronto, Ontario President, The International Society of CNS
Clinical Trials and Methodology, Canada
AC.I.P.CataloguerecordforthisbookisavailablefromtheLibraryofCongress.
ISBN978-1-4020-5777-9(HB)
ISBN978-1-4020-5779-3(e-book)
PublishedbySpringer,
P.O.Box17,3300AADordrecht,TheNetherlands.
www.springer.com
Printedonacid-freepaper
AllRightsReserved
©2007Springer
Nopartofthisworkmaybereproduced,storedinaretrievalsystem,ortransmittedinany
formorbyanymeans,electronic,mechanical,photocopying,microfilming,recording
orotherwise,withoutwrittenpermissionfromthePublisher,withtheexception
ofanymaterialsuppliedspecificallyforthepurposeofbeingenteredandexecuted
onacomputersystem,forexclusiveusebythepurchaserofthework.
CONTENTS
Contributors ix
Foreword xiii
Part I Key Methodological Issues
1. The Distress/Protection Vulnerability Model of Quality
of Life Impairment Syndrome 3
Michael S. Ritsner
2. Role of Dopamine in Pleasure, Reward and Subjective
Responses to Drugs 21
Lakshmi N.P. Voruganti and A. George Awad
3. Neuroendocrine Functions, Mood
and Quality of Life 33
Marianna Mazza and Salvatore Mazza
4. In the Mind of the Beholder Neuronal Mediators for the Effect
of Emotional Experience on Quality of Life 57
Talma Hendler, Roee Admon and David Papo
5. Cross-Cultural Quality of Life Research
in Mental Health 67
Monika Bullinger, Silke Schmidt and Dieter Naber
6. Measuring the Value of Health-Related
Quality of Life 99
Graeme Hawthorne
7. Comparison of Instruments for Measuring the Quality
of Life Impairment Syndrome in Severe Mental Disorders 133
Michael S. Ritsner
v
vi Contents
8. Integrative Bottom-Up Approach to HRQOL Measurement 143
Ralf Pukrop and Andreas Bechdolf
Part II Quality of Life Impairment Syndrome
in Severe Mental Disorders
9. Health Related Quality of Life in Subjects at Risk
for a First Episode of Psychosis 159
Andreas Bechdolf, Verena Veith, Ralf Pukrop
and Joachim Klosterkötter
10. Quality of Life Impairment Syndrome in Schizophrenia 173
Michael S. Ritsner and Anatoly Gibel
11. Insight and Quality of Life in Schizophrenia Spectrum Disorders 227
Paul H. Lysaker and S. Louria
12. Quality of Life and Major Depression 241
Marcelo T. Berlim and Marcelo P.A. Fleck
13. Quality of Life Impairment in Bipolar Disorder 253
Erin E. Michalak Greg Murray Allan H. Young
and Raymond W. Lam
14. Quality of Life Impairment in Anxiety Disorders 275
Margaret A. Koury and Mark Hyman Rapaport
15. Quality of Life in Obsessive-Compulsive Disorder 293
Julio Bobes, M.-P. García-Portilla, Maria-Teresa
Bascarán, Pilar-Alejandra Sáiz, Maria-Teresa Bobes-Bascarán
and Manuel Bousoño
Part III Treatment and Rehabilitation Issues
16. Antipsychotic Medications, Schizophrenia and the Issue
of Quality of Life 307
A. George Awad and Lakshmi N.P. Voruganti
17. Quality of Life Outcomes of ECT 321
Peter B. Rosenquist and W. Vaughn McCall
18. Quality of Life in Mental Health Services 333
Sherrill Evans
Contents vii
19. Subjective Quality of Life in Relation to Psychiatric
Rehabilitation and Daily Life 355
Mona Eklund
20. Cost-Utility Analysis 373
Mojca Z. Dernovsek, Valentina Prevolnik-Rupel and Rok Tavcar
Index 385
CONTRIBUTORS
Roee Admon, Functional Brain Imaging Unit, Wohl Institute for Advanced
Imaging TASMC, Medical Science, Faculty of Medicine, Tel Aviv University,
Israel; [email protected]
A. George Awad, MB, Bch, PhD, FRCPC, Professor Emeritus, Department of
Psychiatry and the Institute of Medical Science University of Toronto, Chief of
Psychiatry, Humber River Regional Hospital, Canada; [email protected]
Maria-Teresa Bascarán, MD, Department of Psychiatry, University of Oviedo,
Spain; [email protected]
Andreas Bechdolf, MD, Consultant Psychiatrist, Cologne Early Recognition and
Intervention Centre for mental crisis – FETZ, Department of Psychiatry and
Psychotherapy, University of Cologne, Kerpenerstr. 6250937 Köln, Germany;
[email protected]
Marcelo T. Berlim, MD, MSc, Depressive Disorders Program and McGill Group
for Suicide Studies, Douglas Hospital Research Centre, McGill University,
Montréal, Quebec, Canada; [email protected]
Julio Bobes, MD, PhD, Department of Psychiatry, University of Oviedo, Spain;
[email protected]
Maria-Teresa Bobes-Bascarán, PhD, Department of Psychiatry, University of
Oviedo, Spain; [email protected]
Manuel Bousoño, MD, PhD, Department of Psychiatry, University of Oviedo,
Spain; [email protected]
Monika Bullinger, MD, Professor, University Medical Centre of Hamburg
Eppendorf Institute and Policlinic for Medical Psychology, Hamburg, Germany;
[email protected]
ix
x Contributors
Mojca Z. Dernovsek, MD, PhD, Assistant Professor, University Psychiatric
Hospital, Institute of Public Health of Republic of Slovenia, Ljubljana, Slovenia;
[email protected]
MonaEklund,Professor,DepartmentofHealthSciences,DivisionofOccupational
Therapy, Lund University, Sweden; [email protected]
Sherrill Evans PhD, Senior Lecturer in Social Work and Social Care; Centre for
Carework Research, Department of Applied Social Sciences, University of Wales,
Swansea; [email protected]
Marcelo P.A. Fleck, MD, PhD, Professor, Department of Psychiatry and Forensic
Medicine; Head, Mood Disorders Program Hospital de Clínicas de Porto Alegre,
Brazil
M.-P. García-Portilla, MD, PhD, Associate Professor, Department of Psychiatry,
University of Oviedo, Spain; [email protected]
Anatoly Gibel, MD, Senior Psychiatrists, Acute Department, Sha’ar Menashe
Mental Health Center, Israel; [email protected]
Graeme Hawthorne, A/Professor, Department of Psychiatry, The University of
Melbourne, Australia; [email protected]
Talma Hendler MD, PhD, Senior lecturer, Psychology Department and Faculty
of Medicine, Tel Aviv University, Director, Functional Brain Imaging Unit,
Wohl Institute for Advanced Imaging, Tel Aviv Sourasky Medical Center, Israel;
[email protected]
Joachim Klosterkötter, MD, Professor of Psychiatry, Chair, Director, Department
of Psychiatry, and Psychotherapy, University of Cologne, Kerpenerstr. 6250937
Köln, Germany; [email protected]
Margaret A. Koury, MS, Research Project Assistant, Cedars-Sinai Health System,
Department of Psychiatry, Los Angeles, USA; [email protected]
Raymond W. Lam, Professor and Head, Division of Clinical Neuroscience,
Department of Psychiatry, University of British Columbia, Vancouver, Canada
Shira Louria, MSW, Research assistant at the Roudebush VA Medical Center and
a doctoral candidate at the University of Indianapolis, School of Psychological
Science, USA
Contributors xi
Paul H. Lysaker, Ph.D., Staff Psychologist at the Roudebush VA Medical Center
and Assistant Professor of Clinical Psychology in the Department of Psychiatry at
theIndianaUniversitySchoolofMedicine,DepartmentofPsychiatry,Indianapolis,
USA; [email protected]
Marianna Mazza, MD, PhD, Institute of Psychiatry, Catholic University of
Sacred Heart, Rome, Italy; [email protected] or marianna.mazza@
rm.unicatt.it
Salvatore Mazza, MD, Professor and Head, Neurophysiopathology Unit,
Department of Neurosciences, Catholic University of Sacred Heart, Rome, Italy
W. Vaughn McCall, MD, MPH, Professor and Chair, Wake Forest University
School of Medicine, Medical Center Blvd., USA
Erin E. Michalak, PhD, Assistant Professor, MSFHR Scholar & CIHR New
Investigator, Mood Disorders Centre, Department of Psychiatry, University of
British Columbia, Vancouver, Canada; [email protected]
Greg Murray, PhD, Senior Lecturer and Clinical Psychologist, Faculty of Life
and Social Sciences, Swinburne University of Technology, Hawthorn, Australia;
[email protected]
Dieter Naber, MD, Professor, University Medical Centre of Hamburg Eppendorf,
Department of Psychiatry, Centre of Psychosocial Medicine, Hamburg, Germany
DavidPapo,FunctionalBrainImagingUnit,WohlInstituteforAdvancedImaging
TASMC, Israel; [email protected]
Valentina Prevolnik-Rupel, BA, MSc, Ministry of Health of Republic of Slovenia,
Ljubljana, Slovenia
Ralf Pukrop, PhD, ScMD, Associate Professor, Section of Experimental and
Clinical Psychology, Department of Psychiatry and Psychotherapy, University of
Cologne, Kerpenerstr. 6250937 Köln Germany; [email protected]
Mark Hyman Rapaport, MD, Chairman, Department of Psychiatry, The Polier
Endowed Chair in Schizophrenia, and Related Disorders, Cedars-Sinai Medical
Center, Department of Psychiatry, Los Angeles, USA; [email protected]
Michael S. Ritsner, MD, PhD, Associate Professor, Department of Psychiatry,
The Rappaport Faculty of Medicine, Technion - Israel Institute of Technology;
and Director, Acute Department, Sha’ar Menashe Mental Health Center, Israel;
[email protected]